Science Day

CSSI Science Day group photo

CSSI’s annual Science Day meeting brings together stakeholders across the cancer research continuum to explore emerging research opportunities and promote new collaborations. Attendees include members of CSSI, representatives across NCI/NIH and other federal agencies, and members of the extramural research community. Meetings cover important trends in cancer research and include high-level talks, brief presentations on CSSI and NCI activities, and group breakout discussions.




2018 Program Book2018 Program Book


2017Program Book2017 Program Book


2016 Program BookProgram Book

Sean Hanlon Presentation

2017 CSSI Science Day: Sean Hanlon, CSSI OD

CSSI Associate Director Dr. Sean Hanlon kicked off the 5th annual Science Day meeting with a summary of the evolution of CSSI. He highlighted the progress of large-scale initiatives like the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and the Cancer Genome Atlas (TCGA) and pilot studies exploring data science and remote health monitoring.

Berny-Lang presentation

2017 CSSI Science Day: Michelle Berny-Lang, CSSI OD

Program Director Dr. Michelle Berny-Lang outlined the goals of the Science Day meeting and acknowledged the participants across government, industry, and academia that make the meeting possible.

Dickherber presentation

2017 CSSI Science Day: Tony Dickherber, CSSI OD, IMAT

Program Director Dr. Tony Dickherber provides a summary of the Innovative Molecular Analysis Technologies (IMAT) program, which supports the development of technologies that advance cancer research and care. He broke down the IMAT portfolio over time to illustrate the changing needs in the cancer research community.

Morris presentation

2017 CSSI Science Day: Stephanie Morris, OCNR

Office of Cancer Nanotechnology Program Director Dr. Stephanie Morris outlined emerging nanotechnology research resulting from the Alliance for Nanotechnology Research.

Kinsinger presentation

2017 CSSI Science Day: Christopher Kinsinger, OCCPR

Office of Cancer Clinical Proteomics Research Program Director Dr. Chris Kinsinger discussed ten years of proteomics research and the evolution of the Clinical Proteomic Tumor Analysis Consortium (CPTAC).